Longevity Vandria moves Alzheimer’s candidate forward after Phase 1 signalBy adminDecember 3, 20250 Early biomarker engagement and clean safety data position VNA-318 as a potential new entrant in longevity-focused neurotherapeutics. Vandria has reported…